The reiteration of a Buy rating and a high price target of $110 by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence in investors and could lead to a positive short term impact on Vir Biotechnology's stock price. Analyst ratings, especially from well-regarded firms, often influence investor perception and can lead to price movements.